Sign In

Friday, June 02, 2017 - 8:00 am to Saturday, June 03, 2017 - 12:30 pm

Overview

Note: This event was held June 2-3, 2017 in San Diego, CA.

Conference participants met to discuss clinically relevant information on the diagnosis, management, and treatment of all types of liver disease including controversies and treatment strategies commonly seen in clinical practice.

Program Chairs

  • K. Rajender Reddy, MD, FAASLD
  • Mark J. Czaja, MD, FAASLD

Content Providers

  • HoChong Gilles, RN, MS, FNP-C
  • Patrick M. Horne, MSN, ARNP, FNP-BC
  • April G. Morris, FNP

Credits Offered

  • Continuing Medical Education (CME): 12.25 AMA PRA Category 1 Credits™
  • Continuing Education (CE): 12.25 Contact Hours
  • Pharmacology Education: 2.0 Pharmacology Credits

Claim your continuing education credits up until Monday, July 17, 2017.

 

Session I: Recent Advances in Hepatology

Friday, June 2
Moderator: K. Rajender Reddy, MD, FAASLD

  • 8-8:05 am    
    Welcome and Introduction
    K. Rajender Reddy, MD, FAASLD
  • 8:05-8:30 am     
    Non-Invasive Diagnosis and Staging of Liver Disease
    Jayant A. Talwalkar, MD, MPH, FAASLD
  • 8:30-8:55 am     
    Genetic Markers in Liver Disease Diagnosis and Treatment
    Frank Lammert, MD
  • 8:55-9:20 am    
    FXR: What it is and How it Can Be Targeted for the Treatment of Liver Diseases
    Christopher L. Bowlus, MD
  • 9:20-9:45 am    
    Contribution of the Microbiota in Liver Disease and its Therapy
    Bernd Schnabl, MD
  • 9:45-10:05 am     
    Panel Discussion
  • 10:05-10:20 am    
    Break

Session II: Cirrhosis, Portal Hypertension, and Beyond

Friday, June 2
Moderator: HoChong Gilles, RN, MS, FNP-C

  • 10:20-10:45 am
    Nutritional Issues in Advanced Liver Disease
    Jennifer C. Lai, MD 
  • 10:45-11:10 am   
    Pulmonary Complications of Liver Disease
    Michael B. Fallon, MD, FAASLD
  • 11:10-11:35 am
    Advances in the Management of Ascites and Variceal Hemorrhage
    Juan G. Abraldes, MD
  • 11:35 am–Noon  
    Care of the Patient with Acute Liver Failure
    Ram M. Subramanian, MD
  • Noon–2:20 pm   
    Panel Discussion
  • 12:20 pm-1:30 pm  
    Lunch
  • Breakout Session (Lunch Served) 
    Preventative Health Strategies in the Outpatient Management of Cirrhosis
    HoChong Gilles, RN, MS, FNP-C and Patrick M. Horne, MSN, ARNP, FNP-BC

Session III: Therapeutics in Liver Disease

Friday, June 2
Moderator: Mark J. Czaja, MD, FAASLD

  • 1:30 pm-1:55 pm     
    Current and Evolving Treatments for Alcoholic Hepatitis
    Michael R. Lucey, MD, FAASLD
  • 1:55-2:20 pm     
    What Can I Treat My NASH Patients With?
    Kathleen E. Corey, MD, MPH, MMSc
  • 2:20-2:45 pm    
    Do We Have A Treatment For Hepatic Fibrosis?
    Natalie J. Torok, MD, MSc
  • 2:45-3:10 pm    
    Emerging Treatments For Cholestatic Liver Diseases
    Saul J. Karpen, MD, PhD, FAASLD
  • 3:10-3:30 pm    
    Discussion
  • 3:30-3:50 pm     
    Break

Session IV: Medical and Surgical Aspects of Advanced Liver Disease

Friday, June 2
Moderator: K. Rajender Reddy, MD, FAASLD

  • 3:50-4:15 pm     
    Controversial Indications for Liver Transplantation: Alcoholic Hepatitis, HCC Outside of Criteria, and Porto-Pulmonary Hypertension
    Michael R. Lucey, MD, FAASLD
  • 4:15-4:40 pm     
    Principles of ICU Care in Advanced Cirrhosis
    Ram M. Subramanian, MD
  • 4:40-5:05 pm  
    Post-Transplant Care of the Recipient: The Role of the Community Gastroenterologist/Hepatologist
    Jayant A. Talwalkar, MD, MPH, FAASLD
  • 5:05-5:30 pm
    Coagulopathy in Liver Disease
    R. Todd Stravitz, MD
  • 5:30-5:50 pm    
    Panel Discussion

Session V: Miscellaneous Liver Diseases

Saturday, June 3
Moderator: Mark J. Czaja, MD, FAASLD

  • 8-8:25 am
    Wilson Disease: Diagnosis and Uncommon Presentations
    Michael L. Schilsky, MD, FAASLD
  • 8:25-8:50 am     
    Acute on Chronic Liver Failure: Is This a Distinct Entity?
    Patrick S. Kamath, MD
  • 8:50-9:15 am    
    How to Best Find HCC?
    Hashem B. El-Serag, MD, MPH
  • 9:15-9:40 am
    Pediatric Liver Diseases in Adulthood: What the General Gastroenterologist/Hepatologist Should Know
    Saul J. Karpen, MD, PhD, FAASLD
  • 9:40-10 am    
    Discussion
  • 10-10:20 am    
    Break

Session VI: Updates on Viral Hepatitis

Saturday, June 3
Moderator: Patrick M. Horne, MSN, ARNP, FNP-BC 

  • 10:20-10:45 am     
    What Do We Do with the HCV Non-Responder?
    K. Rajender Reddy, MD, FAASLD
  • 10:45-11:10 am    
    Treatment of HCV in Decompensated Cirrhosis: Treat Pre- or Post-Transplant
    K. Rajender Reddy, MD, FAASLD
  • 11:10-11:35 am    
    HBV Therapy: Do We Ever Stop Therapy and When?
    Tram T. Tran, MD, FAASLD
  • 11:35-Noon 
    Hepatitis E: Is it a Concern in the US?
    Timothy J. Davern, MD
  • Noon-12:25 pm   
    Panel Discussion
  • 12:25-12:30 pm    
    Conference Summary and Wrap-Up